Funding Opportunities

• Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R01 Clinical Trials Not Allowed)
  (PAR-20-165)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Heart, Lung, and Blood Institute
  National Library of Medicine
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): Standard dates apply The first standard application due date for this FOA is June 5, 2020.
• Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
  (PAR-20-167)
  National Institutes of Health
  National Institute of Allergy and Infectious Diseases
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  National Human Genome Research Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): August 28, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed)
  (PAR-20-168)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Center for Advancing Translational Sciences
  Office of Behavioral and Social Sciences Research
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): Standard dates apply . The first standard application due date for this FOA is June 1?6?, 2020. by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
  (PAR-20-169)
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Standard dates apply. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date The first standard application due date for this FOA is May 25, 2020.
• New Informatics Tools and Methods to Enhance U.S. Cancer Surveillance Research (U01 Clinical Trial Optional)
  (PAR-20-170)
  National Cancer Institute
  Application Receipt Date(s): November 18, 2020; June 6, 2021; November 18, 2021; June 6, 2022; November 18, 2022; June 6, 2023
• Clinical Trials in Organ Transplantation in Children and Adults (CTOT-CA) (U01 Clinical Trial Optional)
  (RFA-AI-20-029)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): October 9, 2020
• Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)
  (RFA-CA-20-031)
  National Cancer Institute
  Application Receipt Date(s): July 24, 2020; June 24, 2021. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Smoking Machine Adaptor Design Project for ENDS, Cigars, and Heated Tobacco Products (UC2) Clinical Trials Not Allowed
  (RFA-FD-21-003)
  Food and Drug Administration
  Application Receipt Date(s): July 10, 2020 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA
• Implementation Research to Improve Case Finding, Cascade Screening, and Treatment for Familial Hypercholesterolemia (FH) (R61/R33 Clinical Trial Required)
  (RFA-HL-22-006)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): March 8, 2021
• Post-Acute Interventions for the Treatment of Anorexia Nervosa (R34 Clinical Trial Required)
  (RFA-MH-20-500)
  National Institute of Mental Health
  Application Receipt Date(s): October 19, 2020 and June 15,2021 No late applications will be accepted for the Funding Opportunity Announcement.